Physician profile
Savannah E Wright
NPI 1275040305
$10,482.84
in general payments reported to CMS, 2019-2025
48 companies · $3,992 in 2025
The $3,992 reported for 2025 was more than what 98% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $202 · 2023: $2,962 · 2024: $3,200 · 2025: $3,992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $66.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,087.21 |
| Education | $66.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $1,179.13 | 2023-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Novo Nordisk INC | $1,107.72 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $942.67 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $764.73 | 2023-2025 | Evenity, Tepezza, Prolia |
| Mannkind Corporation | $700.78 | 2023-2025 | Afrezza |
| Radius Health, INC. | $507.34 | 2023-2025 | Tymlos |
| Xeris Pharmaceuticals, INC. | $492.53 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Abbott Laboratories | $489.11 | 2023-2025 | Freestyle Libre 3 |
| Insulet Corporation | $365.42 | 2023-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $354.30 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ibsa Pharma INC. | $336.30 | 2023-2025 | Tirosint, Licart, Tirosint |
| Medtronic, INC. | $319.47 | 2022-2025 | Minimed 780g |
| Sequel Med Tech, LLC | $190.84 | 2025 | Twiist |
| Bayer Healthcare Pharmaceuticals INC. | $189.39 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $182.07 | 2024-2025 | Strensiq |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $174.35 | 2023-2024 | Senza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.21 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $164.12 | 2023-2024 | Farxiga, Lokelma |
| Sanofi-Aventis U.S. LLC | $158.36 | 2023-2025 | |
| Recordati_rare_diseases_inc. | $150.38 | 2023-2025 | Isturisa, Signifor Lar |
| Corcept Therapeutics | $140.14 | 2024-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $132.41 | 2023-2025 | |
| Horizon Therapeutics Plc | $131.00 | 2023 | Tepezza |
| Janssen Pharmaceuticals, INC | $113.97 | 2021-2022 | |
| Beta Bionics, INC. | $102.39 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Embecta Corp. | $98.39 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Ascendis Pharma Endocrinology INC | $64.65 | 2025 | Yorvipath |
| Abbvie INC. | $60.81 | 2022-2025 | |
| Kyowa Kirin, INC. | $60.80 | 2024-2025 | Crysvita |
| Verity Pharmaceuticals INC. | $58.45 | 2024-2025 | Tlando |
| Pfizer INC. | $56.06 | 2023-2024 | |
| Neurocrine Biosciences, INC. | $48.28 | 2025 | |
| Amneal Pharmaceuticals LLC | $44.68 | 2023 | Unithroid |
| Urogen Pharma, INC. | $41.39 | 2022 | |
| Ionis Pharmaceuticals, INC. | $36.80 | 2025 | Tryngolza |
| Tersera Therapeutics LLC | $35.39 | 2023 | Xermelo |
| Halozyme INC | $34.27 | 2023 | |
| Chiesi USA, INC. | $33.77 | 2025 | Mycapssa, Myalept |
| Ultragenyx Pharmaceutical INC. | $31.85 | 2023-2024 | Crysvita, Crysvita |
| Ascensia Diabetes Care US INC. | $31.02 | 2025 | |
| Eisai INC. | $30.91 | 2024 | |
| Urovant Sciences INC | $29.62 | 2022 | |
| Blue Earth Diagnostics | $27.87 | 2021 | |
| Madrigal Pharmaceuticals | $27.57 | 2025 | Rezdiffra |
| Astellas Pharma US INC | $27.37 | 2024 | Veozah |
| Amarin Pharma, INC. | $18.12 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $17.87 | 2023 | Inpefa |
| Tactile Systems Technology INC | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savannah Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.